Kanahara, Nobuhisa

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 270

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia

Shiina, A., Kanahara, N., Sasaki, T., Oda, Y., Hashimoto, T., Hasegawa, T., Yoshida, T., Iyo, M., & Hashimoto, K. (2015) · Clinical Psychopharmacology and Neuroscience

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 107

Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis

Tadokoro, S., Okamura, N., Sekine, Y., Kanahara, N., Hashimoto, K., & Iyo, M. (2012) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 92

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia

Suzuki, T., Kanahara, N., Yamanaka, H., Takase, M., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Psychiatry Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 81

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sasaki, T., et al. (2014) · Schizophrenia Research

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 55

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia

Takase, M., Kanahara, N., Oda, Y., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Journal of Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 54

Deficits in auditory P50 inhibition in obsessive-compulsive disorder

Hashimoto, T., Shimizu, E., Koike, K., Orita, Y., Suzuki, T., Kanahara, N., Matsuzawa, D., Fukami, G., Miyatake, R., Shinoda, N., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Obsessive-Compulsive Spectrum DisordersPsychoanalysis and Psychopathology Research

Cited by 41

Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up

Kimura, H., Kanahara, N., Sasaki, T., Komatsu, N., Ishige, M., Muneoka, K., Ino, H., Yoshimura, K., Yamanaka, H., Suzuki, T., et al. (2016) · Journal of Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 26

A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists

Tachibana, M., Kanahara, N., Oda, Y., Hasegawa, T., Kimura, A., & Iyo, M. (2024) · Journal of Clinical Sleep Medicine

Sleep and related disordersCircadian rhythm and melatonin

Cited by 17